Monday , October 23 2017
Home / KEEP BUT DO NOT DISPLAY / Facts / FDA Approves Cialis for Benign Prostatic Hyperplasia

FDA Approves Cialis for Benign Prostatic Hyperplasia

The FDA has approved Cialis (tadalafil) as a once-daily treatment for men with erectile dysfunction and benign prostatic hyperplasia, also known as BPH, as well as for BPH alone. BPH is a condition in which the prostate enlarges, which can cause urinary symptoms. Since many men who have ED also experience the signs and symptoms of BPH, a single medication approved to treat both may be a significant therapeutic option for men. FDA